1st April 2003
National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]
Summary,

GUIDELINE OBJECTIVE(S)

To establish the clinical and cost effectiveness of electroconvulsive therapy (ECT) for depressive illness, schizophrenia, catatonia, and mania

TARGET POPULATION

Adults with depressive illness, schizophrenia, catatonia, or mania

INTERVENTIONS AND PRACTICES CONSIDERED

Electroconvulsive therapy

MAJOR OUTCOMES CONSIDERED

* Clinical effectiveness
o Symptom improvement
o Quality of life
o Adverse effects
* Cost effectiveness